(RBT) Robertet - Overview
Stock: Perfumes, Aromas, Essential Oils, Flavorings, Actives
Dividends
| Dividend Yield | 1.24% |
| Yield on Cost 5y | 1.09% |
| Yield CAGR 5y | 15.60% |
| Payout Consistency | 98.1% |
| Payout Ratio | 21.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 18.3% |
| Relative Tail Risk | -4.79% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.01 |
| Alpha | -2.92 |
| Character TTM | |
|---|---|
| Beta | 0.028 |
| Beta Downside | 0.147 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.78% |
| CAGR/Max DD | -0.10 |
Description: RBT Robertet January 01, 2026
Robertet SA (ticker RBT) is a French-based, vertically integrated producer of natural-origin perfumes, aromas, and specialty chemicals. It operates across four business lines-Raw Materials, Fragrances, Flavors, and Active Ingredients-and supplies organic essential oils and other bio-derived actives to customers in North America, Latin America, Europe, Africa, and the Middle East. Founded in 1850 and headquartered in Grasse, the firm is classified under the GICS Sub-Industry “Commodity Chemicals.”
As of FY 2023, Robertet reported revenue of roughly €1.2 billion with an adjusted EBITDA margin near 12%, reflecting steady demand for natural fragrance and flavor solutions. The company’s growth is closely tied to two macro drivers: (1) the premiumization trend in cosmetics and food-beverage sectors, which is boosting volumes of natural essential oils, and (2) tightening EU regulations on synthetic aromatics, encouraging formulators to switch to bio-based alternatives. A material risk is raw-material price volatility, especially for agricultural feedstocks such as lavender and citrus peels, which can compress margins if not hedged.
For a deeper, data-driven assessment of Robertet’s valuation and risk profile, you may find the analytical tools on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 183.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 6.83 > 1.0 |
| NWC/Revenue: 26.39% < 20% (prev 51.96%; Δ -25.57% < -1%) |
| CFO/TA 0.21 > 3% & CFO 214.2m > Net Income 183.2m |
| Net Debt (139.5m) to EBITDA (317.7m): 0.44 < 3 |
| Current Ratio: 3.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.05m) vs 12m ago -11.38% < -2% |
| Gross Margin: 26.17% > 18% (prev 0.15%; Δ 2602 % > 0.5%) |
| Asset Turnover: 171.4% > 50% (prev 83.98%; Δ 87.40% > 0%) |
| Interest Coverage Ratio: 12.58 > 6 (EBITDA TTM 317.7m / Interest Expense TTM 21.2m) |
Beneish M -2.92
| DSRI: 0.53 (Receivables 201.9m/172.4m, Revenue 1.60b/720.6m) |
| GMI: 0.56 (GM 26.17% / 14.67%) |
| AQI: 1.09 (AQ_t 0.19 / AQ_t-1 0.18) |
| SGI: 2.22 (Revenue 1.60b / 720.6m) |
| TATA: -0.03 (NI 183.2m - CFO 214.2m) / TA 1.01b) |
| Beneish M-Score: -2.92 (Cap -4..+1) = A |
What is the price of RBT shares?
Over the past week, the price has changed by -1.06%, over one month by -3.79%, over three months by +1.45% and over the past year by -0.06%.
Is RBT a buy, sell or hold?
What are the forecasts/targets for the RBT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1035.2 | 23.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 843.9 | 0.8% |
RBT Fundamental Data Overview February 03, 2026
P/E Trailing = 18.9806
P/E Forward = 16.6113
P/S = 2.0978
P/B = 3.234
Revenue TTM = 1.60b EUR
EBIT TTM = 266.4m EUR
EBITDA TTM = 317.7m EUR
Long Term Debt = 180.2m EUR (from longTermDebt, last quarter)
Short Term Debt = 71.2m EUR (from shortTermDebt, last quarter)
Debt = 286.1m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 139.5m EUR (from netDebt column, last quarter)
Enterprise Value = 1.88b EUR (1.76b + Debt 286.1m - CCE 165.0m)
Interest Coverage Ratio = 12.58 (Ebit TTM 266.4m / Interest Expense TTM 21.2m)
EV/FCF = 12.46x (Enterprise Value 1.88b / FCF TTM 150.6m)
FCF Yield = 8.02% (FCF TTM 150.6m / Enterprise Value 1.88b)
FCF Margin = 9.42% (FCF TTM 150.6m / Revenue TTM 1.60b)
Net Margin = 11.46% (Net Income TTM 183.2m / Revenue TTM 1.60b)
Gross Margin = 26.17% ((Revenue TTM 1.60b - Cost of Revenue TTM 1.18b) / Revenue TTM)
Gross Margin QoQ = 19.51% (prev 14.33%)
Tobins Q-Ratio = 1.86 (Enterprise Value 1.88b / Total Assets 1.01b)
Interest Expense / Debt = 1.66% (Interest Expense 4.75m / Debt 286.1m)
Taxrate = 26.02% (20.7m / 79.7m)
NOPAT = 197.1m (EBIT 266.4m * (1 - 26.02%))
Current Ratio = 3.15 (Total Current Assets 617.6m / Total Current Liabilities 195.8m)
Debt / Equity = 0.51 (Debt 286.1m / totalStockholderEquity, last quarter 557.4m)
Debt / EBITDA = 0.44 (Net Debt 139.5m / EBITDA 317.7m)
Debt / FCF = 0.93 (Net Debt 139.5m / FCF TTM 150.6m)
Total Stockholder Equity = 520.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 19.64% (Net Income 183.2m / Total Assets 1.01b)
RoE = 35.23% (Net Income TTM 183.2m / Total Stockholder Equity 520.2m)
RoCE = 38.03% (EBIT 266.4m / Capital Employed (Equity 520.2m + L.T.Debt 180.2m))
RoIC = 24.91% (NOPAT 197.1m / Invested Capital 791.0m)
WACC = 5.35% (E(1.76b)/V(2.04b) * Re(6.02%) + D(286.1m)/V(2.04b) * Rd(1.66%) * (1-Tc(0.26)))
Discount Rate = 6.02% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -5.86%
[DCF Debug] Terminal Value 81.60% ; FCFF base≈118.3m ; Y1≈81.5m ; Y5≈40.9m
Fair Price DCF = 583.5 (EV 1.29b - Net Debt 139.5m = Equity 1.15b / Shares 1.97m; r=5.90% [WACC]; 5y FCF grow -36.45% → 2.90% )
Revenue Correlation: 93.62 | Revenue CAGR: 27.56% | SUE: 0.05 | # QB: 0
EPS next Year (2026-12-31): EPS=48.12 | Chg30d=+0.194 | Revisions Net=+0 | Growth EPS=+5.3% | Growth Revenue=+5.9%